| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Tenax Therapeutics Inc (NASDAQ: TENX)
TENX Technical Analysis
1.5
| As on 11th Jun 2025 TENX STOCK Price closed @ 5.75 and we RECOMMEND Buy for LONG-TERM with Stoploss of 4.51 & Sell for SHORT-TERM with Stoploss of 7.05 we also expect STOCK to react on Following IMPORTANT LEVELS. |
TENXSTOCK Price
| Open | 5.75 | Change | Price | % |
| High | 5.89 | 1 Day | -0.03 | -0.52 |
| Low | 5.65 | 1 Week | -0.33 | -5.43 |
| Close | 5.75 | 1 Month | -0.12 | -2.04 |
| Volume | 10405 | 1 Year | 5.47 | 1953.57 |
| 52 Week High 16.00 | 52 Week Low 0.26 | ||||
NASDAQ USA Most Active Stocks
| HCTI | 0.01 | 0.00% |
| NCNA | 0.16 | 14.29% |
| AMRS | 0.14 | 100.00% |
| NUWE | 0.37 | 60.87% |
| GNLN | 0.01 | 0.00% |
| NVDA | 142.83 | -0.78% |
| HSDT | 1.11 | 32.14% |
| INTC | 20.68 | -6.34% |
| PLUG | 1.38 | 7.81% |
| QUBT | 18.97 | 25.38% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| TENX Daily Charts |
TENX Intraday Charts |
Whats New @ Bazaartrend |
TENX Free Analysis |
|
|
TENX Important Levels Intraday
| RESISTANCE | 6.21 |
| RESISTANCE | 6.06 |
| RESISTANCE | 5.97 |
| RESISTANCE | 5.88 |
| SUPPORT | 5.62 |
| SUPPORT | 5.53 |
| SUPPORT | 5.44 |
| SUPPORT | 5.29 |
TENX Forecast June 2025
| 4th UP Forecast | 39.53 |
| 3rd UP Forecast | 28.7 |
| 2nd UP Forecast | 22 |
| 1st UP Forecast | 15.3 |
| 1st DOWN Forecast | -3.8 |
| 2nd DOWN Forecast | -10.5 |
| 3rd DOWN Forecast | -17.2 |
| 4th DOWN Forecast | -28.03 |
TENX Weekly Forecast
| 4th UP Forecast | 5.92 |
| 3rd UP Forecast | 5.87 |
| 2nd UP Forecast | 5.83 |
| 1st UP Forecast | 5.80 |
| 1st DOWN Forecast | 5.70 |
| 2nd DOWN Forecast | 5.67 |
| 3rd DOWN Forecast | 5.63 |
| 4th DOWN Forecast | 5.58 |
TENX Forecast2025
| 4th UP Forecast | 46.62 |
| 3rd UP Forecast | 33.51 |
| 2nd UP Forecast | 25.41 |
| 1st UP Forecast | 17.31 |
| 1st DOWN Forecast | -5.81 |
| 2nd DOWN Forecast | -13.91 |
| 3rd DOWN Forecast | -22.01 |
| 4th DOWN Forecast | -35.12 |
Tenax Therapeutics Inc ( NASDAQ USA Symbol : TENX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
TENX Business Profile
Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. The company develops levosimendan, which completed a phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction; and Imatinib, a tyrosine kinase inhibitor for the treatment of pulmonary arterial hypertension. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina. Address: ONE Copley Parkway, Morrisville, NC, United States, 27560
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service